BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19114961)

  • 1. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
    Celiński K; Madro A; Prozorow-Król B; Korolczuk A; Cichoz-Lach H; Słomka M; Korobowicz E
    Med Sci Monit; 2009 Jan; 15(1):BR21-9. PubMed ID: 19114961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
    Chen C; Xu S; Wang WX; Ding YM; Yu KH; Wang B; Chen XY
    Arch Med Res; 2009 Feb; 40(2):79-88. PubMed ID: 19237016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of adenosine A2a receptors in experimental acute pancreatitis.
    Celiński K; Prozorow-Król B; Korolczuk A; Słomka M; Korobowicz E; Biskup W; Madro A; Cichoz-Lach H; Czechowska G
    Adv Med Sci; 2006; 51():105-10. PubMed ID: 17357287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of activated protein C on experimental acute necrotizing pancreatitis.
    Yamanel L; Mas MR; Comert B; Isik AT; Aydin S; Mas N; Deveci S; Ozyurt M; Tasci I; Unal T
    Crit Care; 2005 Jun; 9(3):R184-90. PubMed ID: 15987389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
    Ivashchenko CY; Duan SZ; Usher MG; Mortensen RM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G319-26. PubMed ID: 17463185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats.
    Yilmaz M; Topsakal S; Herek O; Ozmen O; Sahinduran S; Buyukoglu T; Yonetci N
    Transl Res; 2009 Nov; 154(5):241-9. PubMed ID: 19840765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
    Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered PPARgamma expression and activation after transient focal ischemia in rats.
    Victor NA; Wanderi EW; Gamboa J; Zhao X; Aronowski J; Deininger K; Lust WD; Landreth GE; Sundararajan S
    Eur J Neurosci; 2006 Sep; 24(6):1653-63. PubMed ID: 17004929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
    Griesbacher T; Pommer V; Schuligoi R; Tiran B; Peskar BA
    Int Immunopharmacol; 2008 Feb; 8(2):325-9. PubMed ID: 18182248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone: a promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis.
    Xu P; Xu K; Wang J; Jiang JP; Chen LQ
    Dig Dis Sci; 2011 Apr; 56(4):1082-9. PubMed ID: 20824499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
    Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
    Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
    Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
    Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
    Allahtavakoli M; Shabanzadeh AP; Sadr SS; Parviz M; Djahanguiri B
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1052-8. PubMed ID: 17042914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.
    Aytan H; Caliskan AC; Demirturk F; Aytan P; Koseoglu DR
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):321-5. PubMed ID: 17627689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.